The Road Towards Optimal Individualized Care of Adolescents and Young Adults with Acute Lymphoblastic Leukemia
Sponsored by Med Learning Group.
This activity is co-provided by Ultimate Medical Academy/CCM.
Supported by an Educational Grant from Jazz Pharmaceuticals Inc.
Scroll to the Bottom of this Information to Begin this Course
Release date: December 17, 2015
Valid through: December 17, 2016
Topic: Acute Lymphoblastic Leukemia (ALL)
Estimated Time to Complete Activity: 60 minutes
This activity is designed to meet the educational needs of hematologists, oncologists, and other healthcare professionals who provide medical care for adolescent and young adult patients with ALL.
This case-based enduring activity will cover the diagnosis, treatment, and management of adolescent and young adult patients with ALL.
Upon completion of the program, attendees should be able to:
- Identify the unique differences and challenges in the management of acute lymphoblastic leukemia (ALL) in adolescent and young adult (AYAs) patients
- Discuss recent clinical evidence and current recommendations for optimizing the therapeutic regimens for AYA ALL patients with pediatric-inspired protocols
- Discuss our current treatment strategies in AYA patients with relapsed ALL
- Physicians — maximum of 1.0 AMA PRA Category 1 Credits™
- Nurses — 1.0 ANCC Credit Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Daniel J. DeAngelo, MD, PhD
Adult Leukemia Program
Dana-Farber Cancer Institute
Brigham and Women’s Hospital
Harvard Medical School
Dan Douer, MD
Clinical Professor of Medicine
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College
New York, NY
MLG Course Reviewer
The content of this activity was independently peer reviewed.
CCM/UMA Lead Nurse Planner
Margaret Governo, EdD, APRN BC
Physician Continuing Medical Education
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of adolescent and young adult patients with acute lymphoblastic leukemia.
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.
Disclosures of Conflicts of Interest
In accordance with the Accreditation Council for Continuing Medical Education (ACCME)Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Dr. DeAngelo has received consultant fees from Novartis, Sigma Tau, BMS, Amgen, and Pfizer; and has received research support from Sigma Tau.
Dr. Douer has received consultant fees from Amgen, Pfizer, Spectrum, and Gilead; and has received research support from BMS and Amgen.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
UMA/CCM Nurse Reviewer - - Margaret Governo, EdD, APRN BC has no relevant financial relationships to disclose.
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Flavia Piazza, PhD, VP Scientific and Medical Services for Med Learning Group has nothing to disclose.
Brooke Hefele, Outcomes Coordinator for Med Learning Group has nothing to disclose.
Lisa Dorin, Program Manager for Med Learning Group has nothing to disclose.
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CME/CNE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Instructions for Participation and Credit
There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the enduring activity.
- Submit the evaluation form to the Med Learning Group.
You will receive your certificate via email within 30 days.
For CME questions, please contact: Med Learning Group at email@example.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/
Hardware and Software Requirements
This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.
Content - Copyright © 2015 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.